Skip to main content

Latest ACR News

      RT @_connectedcare: Ixekizumab in nrAXSpa
      Outcomes met. Another positive trial
      #ACR19 @rheumnow Abst2729 https://t.co/VVUKSi6sCQ

      Dr Irwin Lim _connectedcare

      5 years 1 month ago
      Ixekizumab in nrAXSpa Outcomes met. Another positive trial #ACR19 @rheumnow Abst2729 https://t.co/VVUKSi6sCQ
      RT @_connectedcare: Ixekizumab in nrAXSpa: COAST-X
      switch at wk16 for 52wk study
      IXE 2wkly vs 4wkly vs PBO
      303pts
      #ACR19 @rheumnow Abst2729

      Dr Irwin Lim _connectedcare

      5 years 1 month ago
      Ixekizumab in nrAXSpa: COAST-X switch at wk16 for 52wk study IXE 2wkly vs 4wkly vs PBO 303pts #ACR19 @rheumnow Abst2729
      RT @uptoTate: @KDAO2011 teaching us about SLE @RheumNow #ACR19 it’s almost your last chance to swing by the rheumnow booth! https://t.co/pB…

      Dr. Rachel Tate uptoTate

      5 years 1 month ago
      @KDAO2011 teaching us about SLE @RheumNow #ACR19 it’s almost your last chance to swing by the rheumnow booth! https://t.co/pBdFAwGXtm
      Dr Atul Deodhar wows the crowd at #ACR19 showing abtract #2729 Ixekizumab in Non-Radiographic Axial Spondyloarthritis: Phase 3 Trial showing IXE is ef

      Dr. John Cush RheumNow

      5 years 1 month ago
      Dr Atul Deodhar wows the crowd at #ACR19 showing abtract #2729 Ixekizumab in Non-Radiographic Axial Spondyloarthritis: Phase 3 Trial showing IXE is effective by ASAS40. https://t.co/Bcb20FYNoH
      RT @hausmannMD: How should VECTRA be used, if at all?
      -Bathon I don't use VECTRA routinely, it's as good as your physical exam.
      -Bykerk: I'…

      Jonathan Hausmann MD hausmannMD

      5 years 1 month ago
      How should VECTRA be used, if at all? -Bathon I don't use VECTRA routinely, it's as good as your physical exam. -Bykerk: I've yet to find a good reason to use it. -Emery ::no comment:: -Mikuls: I don't think there's a place in my clinic to use it. #ACR19 @RheumNow
      RT @drdavidliew: @cappelliMD @Richter_MD @LCalabreseDO @CCalabreseDO @lexmeara @UmaThanaMD Nice work @Richter_MD - such an important phenom…

      David Liew drdavidliew

      5 years 1 month ago
      @cappelliMD @Richter_MD @LCalabreseDO @CCalabreseDO @lexmeara @UmaThanaMD Nice work @Richter_MD - such an important phenomenon. It’s always something nice to tell my melanoma irAE patients: your arthritis might be nasty, but at least there’s a substantive upside! #ACR19 ABST2137 @RheumNow (sorry to miss you in person!) https://t.co/x1T9n9eekG
      RT @hausmannMD: 38yo F with seroneg RA on 3x therapy with synovitis. What tx do you choose?
      -Bathon: Confirm dx, use biologic, avoid ritux…

      Jonathan Hausmann MD hausmannMD

      5 years 1 month ago
      38yo F with seroneg RA on 3x therapy with synovitis. What tx do you choose? -Bathon: Confirm dx, use biologic, avoid ritux -Bykerk: Ask about JIA, use TNF, JAK, IL-6 -Emery: Not ritux. Use steroids, consider TNFi, urgent tx is not needed -Mikuls: Agree with above #ACR19 @RheumNow
      RT @EBRheum: @RheumNow Should note this was not the first JAKi in this space; similar trial using tofacitinib in 2017 https://t.co/NrEul0wL…

      Mike Putman EBRheum

      5 years 1 month ago
      @RheumNow Should note this was not the first JAKi in this space; similar trial using tofacitinib in 2017 https://t.co/NrEul0wLp9
      RT @EBRheum: #ACR19 Abst#2728 Plenary: Upadacitinib RCT in AnkSpa

      Improved ASAS40 at wk14 (52% v 26% PLBO, NNT~4) and SPARCC MRI Scores.…

      Mike Putman EBRheum

      5 years 1 month ago
      #ACR19 Abst#2728 Plenary: Upadacitinib RCT in AnkSpa Improved ASAS40 at wk14 (52% v 26% PLBO, NNT~4) and SPARCC MRI Scores. Good safety profile but too small a trial to assess properly Overall an encouraging result, JAKi impacting yet another disease! @RheumNow https://t.co/GtB9wHuoNp
      RT @_connectedcare: Upadacitinib in AS
      Nice to the rapid response
      #ACR19 @rheumnow Abst2728 https://t.co/woAZbdb5QY

      Dr Irwin Lim _connectedcare

      5 years 1 month ago
      Upadacitinib in AS Nice to the rapid response #ACR19 @rheumnow Abst2728 https://t.co/woAZbdb5QY
      RT @hausmannMD: What's your option for RA patients with MTX failure?
      -Bathon: Triple therapy vs. biologic (etanercept or adalimumab)
      -Byker…

      Jonathan Hausmann MD hausmannMD

      5 years 1 month ago
      What's your option for RA patients with MTX failure? -Bathon: Triple therapy vs. biologic (etanercept or adalimumab) -Bykerk: Maximize MTX to 25mg SQ -Emery: Adalimumab is our cheapest and most effective therapy -Mikuls: Usually TNFi, typically etanercept #ACR19 @RheumNow
      RT @MaeveGamble: Do you hold MTX in men who want to conceive? #ACR19 @RheumNow

      Maeve Gamble MaeveGamble

      5 years 1 month ago
      Do you hold MTX in men who want to conceive? #ACR19 @RheumNow
      RT @_connectedcare: Upadacitinib in AS
      And here’s the Safety Slide
      #ACR19 @rheumnow Abst2728 https://t.co/fpjhrjGp0N

      Dr Irwin Lim _connectedcare

      5 years 1 month ago
      Upadacitinib in AS And here’s the Safety Slide #ACR19 @rheumnow Abst2728 https://t.co/fpjhrjGp0N
      Looking forward to this PsA panel talk #ACR2019 https://t.co/pCMaqQCMsJ

      Dr. John Cush RheumNow

      5 years 1 month ago
      Looking forward to this PsA panel talk #ACR2019 https://t.co/pCMaqQCMsJ
      RT @MaeveGamble: For new diagnosis of RA: How often do you bridge with prednisone?
      #ACR19 @RheumNow

      Maeve Gamble MaeveGamble

      5 years 1 month ago
      For new diagnosis of RA: How often do you bridge with prednisone? #ACR19 @RheumNow
      ×